BioCentury
ARTICLE | Company News

MorphoSys sales and marketing update

November 22, 2010 8:00 AM UTC

MorphoSys launched its arYla technology to accelerate antibody optimization. arYla was derived from the combined technology platforms of MorphoSys and recently acquired Sloning BioTechnology GmbH (see...